6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

NCT07463313 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Thymoma and Thymic Carcinoma

Interventions

DRUG: Cyclophosphamide, Doxorubicin, and Cisplatin (CAP)
DRUG: nab-Paclitaxel and Carboplatin

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine